MULTIPLE ANALYTE URINE DRUGS OF ABUSE CALIBRATORS AND CONTROLS
K051088 · Lin-Zhi International, Inc. · DKB · Jun 24, 2005 · Clinical Toxicology
Device Facts
Record ID
K051088
Device Name
MULTIPLE ANALYTE URINE DRUGS OF ABUSE CALIBRATORS AND CONTROLS
Applicant
Lin-Zhi International, Inc.
Product Code
DKB · Clinical Toxicology
Decision Date
Jun 24, 2005
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 862.3200
Device Class
Class 2
Indications for Use
The Multiple Analyte (Benzoylecgonine, Methamphetamine, Methadone, Morphine. Oxazepam, Secobarbital, Phencyclidine, and Propoxyphene) Urine Drugs of Abuse Calibrators intended for in vitro diagnostic use for the calibration of their respective enzyme immunoassays to detect d-methamphetamine, benzoylecgonine, opiate, benzodiazepines. barbiturates, methadone, phencyclidine or propoxyphene in human urine. The Multiple Analyte (Benzoylecgonine, Methamphetamine, Methadone, Morphine, Oxazepam, Secobarbital, Phencyclidine, and Propoxyphene) Urine Drugs of Abuse Controls are intended for in vitro diagnostic use for the validation of their respective enzyme immunoassays to detect d-methamphetamine, benzoylecgonine, opiate, benzodiazepines, barbiturates, methadone, phencyclidine or propoxyphene in human urine.
Device Story
Liquid, ready-to-use calibrators and controls; human urine matrix spiked with known concentrations of drug analytes (benzoylecgonine, methamphetamine, methadone, morphine, oxazepam, secobarbital, phencyclidine, propoxyphene). Used in clinical laboratory settings by technicians to calibrate and validate enzyme immunoassay (EIA) systems for drugs of abuse testing. Calibrators establish assay response curves; controls verify assay performance and accuracy. Values confirmed via GC/MS. Provides standardized reference points for clinical decision-making regarding drug screening results.
Clinical Evidence
No clinical data. Bench testing only. Stability demonstrated over 244 days at 2-8°C and room temperature; concentrations confirmed by GC/MS and HPLC; traceability to USP reference materials established.
Technological Characteristics
Liquid, ready-to-use urine matrix. Calibrators/controls contain spiked drug analytes. Concentrations confirmed by GC/MS and HPLC. Storage at 2-8°C. Designed for use on automated clinical chemistry analyzers.
Indications for Use
Indicated for in vitro diagnostic use in clinical laboratories to calibrate and validate enzyme immunoassays for the detection of d-methamphetamine, benzoylecgonine, opiates, benzodiazepines, barbiturates, methadone, phencyclidine, or propoxyphene in human urine samples.
Regulatory Classification
Identification
A clinical toxicology calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. A clinical toxicology calibrator can be a mixture of drugs or a specific material for a particular drug (e.g., ethanol, lidocaine, etc.). (See also § 862.2 in this part.)
Special Controls
*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
Predicate Devices
Drugs of Abuse Urine Calibrators and Controls (K993755)
DRI Drugs of Abuse Urine Calibrators and Controls (K983159)
Submission Summary (Full Text)
{0}
1
# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE
A. 510(k) Number:
k051088
B. Purpose for Submission:
Notification of intent to manufacture and market the device: LZI Multiple Analyte Urine Drugs of Abuse Calibrators and Controls
C. Measurand:
Benzoylecgonine, Methamphetamine, Methadone, Morphine, Oxazepam, Secobarbital, Phencyclidine, and Propoxyphene
D. Type of Test:
Calibrators and Control Materials
E. Applicant:
Lin-Zhi International, Inc.
F. Proprietary and Established Names:
Proprietary Name – None
Established Name – Drug Mixture Calibrator
Drug Mixture Control
G. Regulatory Information:
1. Regulation section:
21 CFR 862.3200 Clinical toxicology, Drug Mixture
21 CFR 862.3280 Clinical toxicology control material
2. Classification:
Class II – calibrator
Class I – control
3. Product code:
DKB – calibrator
DIF – control
4. Panel:
Toxicology (91)
H. Intended Use:
1. Intended use:
Refer to Indications for use
{1}
2. Indications for use: Multi-Analyte (Benzoylecgonine, Methamphetamine, Methadone, Morphine, Oxazepam, Secobarbital, Phencyclidine, and Propoxyphene) Urine Drugs of Abuse Calibrators are intended for in vitro diagnostic use for the calibration of their respective enzyme immunoassays to detect $d$ -methamphetamine, benzoylecgonine, opiate, benzodiazepines, barbiturates, methadone, phencyclidine, or propoxyphene in human urine.
Multi-Analyte (Benzoylecgonine, Methamphetamine, Methadone, Morphine, Oxazepam, Secobarbital, Phencyclidine, and Propoxyphene) Urine Drugs of Abuse Controls are intended for in vitro diagnostic use for the validation of their respective enzyme immunoassays to detect $d$ -methamphetamine, benzoylecgonine, opiate, benzodiazepines, barbiturates, methadone, phencyclidine, or propoxyphene in human urine.
3. Special conditions for use statements: For in vitro diagnostic use For prescription use
4. Special instrument requirements: Automated clinical chemistry analyzer
I. Device Description: The calibrators and controls are liquid and ready to use. These calibrators and controls contain a known concentration of a mixture of specific drug analytes. The Negative Calibrator is a processed, drug free urine matrix. The Low, Cutoff, Intermediate and High Calibrators are prepared by spiking known concentrations of drug analyte into the Negative Calibrator matrix. Control Level 1 and 2 are prepared by spiking known concentrations of drug analyte into the Negative Calibrator matrix. The following concentrations of each drug analyte in their corresponding calibrators and controls are summarized:
| | Low Calibrator | Cutoff Calibrator | Intermediate Calibrator | High Calibrator | | Control Level 1 | Control Level 2 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Material | ng/mL | Ng/mL | ng/mL | ng/mL | | ng/mL | ng/mL |
| Methamphetamine | 250 | 500 | 750 | 1000 | | 375 | 625 |
| Secobarbital | 100 | 200 | 500 | 1000 | | 100 | 300 |
| Oxazepam | 100 | 200 | 500 | 1000 | | 100 | 300 |
| Benzoylecgonine | 75 | 150 | 300 | 1000 | | 110 | 190 |
| Methadone | 150 | 300 | 600 | 1000 | | 225 | 375 |
| Morphine | 1000 | 2000 | 4000 | 6000 | | 1500 | 2500 |
| Phencyclidine | 12.5 | 25 | 50 | 100 | | 18 | 35 |
| Propoxyphene | 150 | 300 | 600 | 1000 | | 225 | 375 |
J. Substantial Equivalence Information:
{2}
1. Predicate device names: DRI, now Microgenics Dade Behring
2. Predicate 510(k) numbers: k993755 k983159
3. Comparison with predicate:
| Similarities | | | |
| --- | --- | --- | --- |
| Characteristic | Lin-Zhi International | DRI, now Microgenics | Dade Behring, Syva |
| Intended Use: | Intended for in vitro diagnostic use for the calibration and validation of LZI DAU enzyme immunoassays to detect methamphetamine, opiate, phencyclidine, benzoylecgonine, benzodiazepines, barbiturates, methadone, and propoxyphene in human urine. | Intended for in vitro diagnostic use for the calibration and validation of drug of abuse enzyme immunoassays for the detection of amphetamines, barbiturate, benzodiazepines, cocaine metabolite, methadone, methaqualone, morphine, phencyclidine and propoxyphene in human urine. | Used in the calibration of the Emit II Plus Barbiturate, Benzodiazepines, Cannabinoid, Cocaine Metabolite, Methadone, Methaqualone, Amphetamines, Methamphetamine, Opiate, Phencyclidine, and Propoxyphene Assays. |
| Levels | Total of 7 levels, including Negative. | Same | Total of 6 levels, including Negative. |
| Format | Liquid | Same | Same |
| Matrix | Urine | Same | Same |
| Storage | When not in use, bottles should be capped at all time and refrigerated at 2-8°C. | The Calibrators and Controls should be stored refrigerated at 2-8°C when not in use. | Always store the calibrators/controls refrigerated at 2-8°C (36-46°F) when not in use. Store upright. Do not freeze or expose to temperature above 32°C (90°F). |
| Differences | | | |
| --- | --- | --- | --- |
| Characteristic | Lin-Zhi International | DRI, now Microgenics | Dade Behring, Syva |
| Cutoffs for Benzoylecgonine, Methamphetamine | 2004 SAMHSA guidelines: ng/mL 150, 500 | Previous SAMHSA guidelines: ng/mL 150, 500 | Previous SAMHSA guidelines: ng/mL 300, 1000 |
{3}
| Drugs | methamphetamine, opiate, phencyclidine, benzoylecgonine, benzodiazepines, barbiturates, methadone, and propoxyphene | 300, 1000 | barbiturate, benzodiazepines, cannabinoid, cocaine metabolite, methadone, methaqualone, morphine, phencyclidine and propoxyphene |
| --- | --- | --- | --- |
K. Standard/Guidance Document Referenced (if applicable): No Standard or Guidance Document was referenced in this submission
L. Test Principle: N/A
M. Performance Characteristics (if/when applicable):
1. Analytical performance:
a. Precision/Reproducibility:
b. Linearity/assay reportable range: N/A
c. Traceability, Stability, Expected values (controls, calibrators, or methods): The calibrators and controls are purchased from a supplier of analytical standards which provides documented traceability to drug standards. The supplier provides a certificate of analysis which includes the description of the material, reference material code and batch number, the certified values, the level of homogeneity and the data generated by GC/MS and HPLC. The concentrations of the calibrators and controls were confirmed with GC/MS. In addition some of the calibrators and controls are compared to calibration curves prepared from USP Reference Materials.
Stability
The calibrators and controls were split into two 15-mL vials with dropper tip and screw-on cap. When not in use, these vials were always capped. One set of aliquots containing the different levels of calibrators and controls were stored at 2-8°C while the other set of aliquots were stored at room temperature, 22-25°C. The signals produced by the assays were compared at day 1, day 143, day 189 and day 244. The data demonstrates that the analytes are stable in the matrix; there is no significant difference in rate produced by the two sets of calibrators/controls. Based on these studies, the stability is expected to be at least 18 months. The sponsor specifies the concentrations of materials evaluated in the studies, the frequency of testing, the method for testing the materials, and the environmental conditions of storage. Accelerated studies are being used by the sponsor to estimate the expiration date; however, on-going real time studies are being performed.
{4}
Expected Values
The Negative Calibrator is a processed, drug free urine matrix. The Low, Cutoff, Intermediate and High Calibrators are prepared by spiking known concentrations of drug analyte into the Negative Calibrator matrix. Control Level 1 and 2 are prepared by spiking known concentrations of drug analyte into the Negative Calibrator matrix. The concentrations are confirmed by GC/MS. Refer to section I for drug concentrations in the calibrators/controls.
d. Detection limit: N/A
e. Analytical specificity: N/A
f. Assay cut-off: N/A
2. Comparison studies:
a. Method comparison with predicate device: N/A
b. Matrix comparison: N/A
3. Clinical studies:
a. Clinical Sensitivity: N/A
b. Clinical specificity: N/A
c. Other clinical supportive data (when a. and b. are not applicable): N/A
4. Clinical cut-off: N/A
5. Expected values/Reference range: N/A
N. Proposed Labeling:
The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.
O. Conclusion:
The submitted information in this premarket notification is complete and supports a substantial equivalence decision.
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.
Copy this now. It will not be shown again.
Connected apps
Apps you authorized through browser sign-in. Disconnecting revokes their access immediately.
Learn the FDA Browser
Two short videos show you everything — or skip straight to the written tutorial if you'd rather read. You can reopen this any time from the Tutorial button in the top bar.
Part 1 — Search, results, and everyday workflows 16 min
Part 2 — Embeddings: the galaxy map 3 min
1. Search: exact and fuzzy
Type a phrase like "coronary artery calcification" into the search box. You get two kinds of results. Exact results match the literal phrase — prefix searches work ("coronary artery calcificati") but suffix searches do not. Fuzzy results match on the meaning and intent of your phrase rather than the exact words, and are sorted by relevance score. Hover over the Exact or Fuzzy badge on any row to see exactly why it matched.
Use the checkboxes above the results to narrow: SaMD keeps only software-only devices, AI / ML keeps only devices with AI.
Exact vs. fuzzy search: what's the difference?
Exact matches on the literal phrase (prefix search works, suffix does not). Fuzzy matches on the meaning and intent of the phrase rather than the exact words. Hover over the badge on any row to see why it matched.
You search "coronary artery calcification" and want only software devices with AI. What two filters do you apply?
Narrow by SaMD (software-only devices), then narrow by AI/ML (devices with AI).
2. The results table
Scroll right in the results table. The intended use is extracted for you — no need to open the PDF. The device story gives a high-level snapshot of what the device does and how it's used. The AI Performance sub-table shows each output name, acceptance criteria, observed values, and development/test dataset descriptions — the same format Innolitics uses for regulatory strategy outputs, and the fastest high-level fingerprint of an AI device. It is AI-generated but has been very reliable in practice.
Where do you find a device's intended use without opening the PDF?
Scroll right in the search results table. The intended use column is extracted for you; no need to dig into the 510(k) summary PDF.
What does the AI Performance sub-table show, and why is it useful?
Output name, acceptance criteria, observed values, development dataset description, and test dataset description. It's the same format we use for regulatory strategy output and Fast 510(k) input, and the fastest high-level fingerprint of an AI device. AI-generated but reliable in practice.
3. Judging fuzzy relevance
Fuzzy results trail off in relevance as you scroll. Use three signals to decide how far down to go: the fuzzy badge explanations, the intended use column, and whether your target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, you're past the relevant zone. A top hit with a low score (~0.4) and a stretched explanation is a hint the closest predicates are far away — the project may be headed for De Novo. Note the fuzzy search is a pattern match: it doesn't handle negation ("not") well, and hardware devices can appear — filter by SaMD/AI ML to cut them.
How do you judge how far down fuzzy search results to go?
Use the relevancy signals: the fuzzy badge explanations, the intended use column, and whether the target output (e.g., Cobb angle) still appears in the AI Performance sub-table. Once it stops appearing, results are trailing off in relevancy.
4. Device detail page: chat and citations
Click a device name to open its detail page: device facts on the left, a chat window on the right. Ask something like "Describe the training data". The answer carries little citation bubbles — click one to jump to the highlighted passage in the source PDF, so you can verify every AI answer against the document. There's also a Download PDF button for sharing.
How do you verify an AI chat answer on the device detail page?
Click the citation bubbles to jump to the relevant highlight in the source document.
Reading rule for every project: how many summaries do you read in full?
At least the three most relevant 510(k) or De Novo summaries, in full. After that, use targeted chat questions to confirm your memory quickly. The tool supports this professional habit — it doesn't replace it.
5. Side-by-side comparison
Select multiple rows in the results table (aim for under ~10), then open the PDF Viewer tab. Ask one question — it goes to all selected devices in parallel, each with citations. This is the fastest way to compare and contrast devices: training data, PCCP scope, how they handled adding new scanners, and so on.
What does the side-by-side PDF viewer mode do?
Select multiple devices, open the PDF viewer tab, and ask one question (e.g., "Describe the training data"). It queries all selected devices simultaneously with citations, so you can compare and contrast quickly.
6. Collections
With rows selected, go to the Collections tab and create a labeled collection (e.g., "Cobb Angle Project"). Reload that selection any time — before a client call, pull up the collection and ask questions across all of its devices at once.
How do you save a set of selected devices for later use?
Select the rows, go to the Collections tab, and create a labeled collection (e.g., "Cobb Angle Project"). You can reload the selection anytime and carry it into the PDF viewer and other tabs that support selections.
7. Product codes and the regulations tree
Click a product code in the results to jump to it in the regulations tree — identification text, sibling product codes, and devices you can open in a PDF viewer on the right. Click a regulation number to see its identification, special controls, and related product codes. You can also search by product code or regulation number at the top of the tree. Always read the special controls if any exist for your device — it broadens your search and sharpens pre-kickoff research.
What can you do from the regulations tree view?
Browse product codes and regulation numbers, read the identification text and special controls, browse sibling product codes, open device PDFs on the right, and search by product code or regulation number at the top of the tree.
8. Chart view
Click Show Chart and segment by regulation number (or product code) to see which regulations dominate your result set. Clicking a regulation takes you into the regulations tree. Great for spotting that most matches are, say, hardware laparoscopic devices — a cue to go back and filter.
How do you see which regulations dominate a search result set?
Click "Show Chart" and segment by Regulation Number. Clicking a regulation takes you to the regulations tree.
9. The predicate graph
Open the Predicates tab for a family-tree view of predicate relationships. Click a node to trace its parents and children; selections from search carry over pre-selected. Commonly predicated devices are worth reading — a lot of people predicated them for a reason. The visual lineage is also handy on client calls, e.g. to show how a predicate family evolved and justify why your predicate still holds.
In the predicate graph, why are commonly predicated devices worth reading?
A lot of people predicated them for a reason. Clicking a node traces parents and children, and selections from search carry over pre-selected.
10. Embeddings: the galaxy map
The Embeddings tab plots every matching document in a 2-D "galaxy map" where semantically similar devices cluster together. Hover or click clusters to explore, and let AI label the clusters for you. Embeddings beat product codes for grouping: two devices can carry different product codes (LLZ vs. QIH) yet do the same thing — the embedding captures the meaning of the intended use and device story. This is also exactly how retrieval-augmented generation (RAG) works under the hood, and it makes a great visual on client calls.
Try it yourself
Head to the search page and work through a few of these AI/ML fuzzy searches to build intuition: perivascular fat on CT · aortic valve calcification opportunistic screening on noncontrast CT · breast cancer prediction on digital pathology slides · autism detection · gestational age prediction · a hearing aid that can also detect a pulse · foundation model based analysis of ECG · large language models · penetration test. Watch how the relevance scores, intended use, and AI Performance tables tell you when results stop being meaningful.
